You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

beta-glucosidase,

Showing 1 - 25 of 3,085
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Columbus (Arm I Soy Bread, Arm II Soy-Almond Bread)

Active, not recruiting
  • Recurrent Prostate Cancer
  • Stage IV Prostate Cancer
  • Arm I Soy Bread
  • Arm II Soy-Almond Bread
  • Columbus, Ohio
    The Ohio State University Medical Center
Apr 29, 2022

Healthy Trial in Madison (Purple-Red Carrot Juice, Red Carrot Juice, Purple Carrot Juice)

Recruiting
  • Healthy
  • Purple-Red Carrot Juice
  • +2 more
  • Madison, Wisconsin
    UW-Madison Department of Nutritional Sciences
Jan 23, 2023

Lyso-Gb1 as a Long-term Prognostic Biomarker in Gaucher Disease

Completed
  • Lysosomal Storage Diseases
  • +2 more
    • Tirana, Albania
    • +7 more
    May 27, 2021

    Healthy, Safety Issues Trial (Polyphenolic beverage from extract of Vachellia farnesiana, Placebo)

    Withdrawn
    • Healthy
    • Safety Issues
    • Polyphenolic beverage from extract of Vachellia farnesiana
    • Placebo
    • (no location specified)
    Mar 27, 2023

    Pompe Disease, Muscle Loss, Obesity Trial (Multi-ingredient supplement (PDT-MIS), Placebo (PLA))

    Not yet recruiting
    • Pompe Disease
    • +7 more
    • Multi-ingredient supplement (PDT-MIS)
    • Placebo (PLA)
    • (no location specified)
    Nov 8, 2023

    Acute Ischemic Stroke, Basilar Artery Occlusion Trial in Beijing (Best medical management, Endovascular treatment)

    Recruiting
    • Acute Ischemic Stroke
    • Basilar Artery Occlusion
    • Best medical management
    • Endovascular treatment
    • Beijing, Beijing, China
      Beijing Tiantan Hospital
    Oct 20, 2023

    Pompe Disease Infantile-Onset Trial in China (GC301)

    Not yet recruiting
    • Pompe Disease Infantile-Onset
    • GC301
    • Beijing, China
    • +4 more
    Apr 2, 2023

    Infantile-onset Pompe Disease Trial in Beijing (Genetic: GC301)

    Recruiting
    • Infantile-onset Pompe Disease
    • Genetic: GC301
    • Beijing, Beijing, China
      Bayi Children's Hospital, Seventh Medical Center, PLA general ho
    Sep 30, 2022

    Prediabetes Trial in Seberang Jaya (Oil Palm Phenolics, Placebo)

    Withdrawn
    • Prediabetes
    • Oil Palm Phenolics
    • Placebo
    • Seberang Jaya, Penang, Malaysia
      Seberang Jaya Hospital
    Sep 28, 2021

    Obesity Trial in New Brunswick (300 mg SC, 500 mg SC, Placebo)

    Completed
    • Obesity
    • 300 mg SC
    • +2 more
    • New Brunswick, New Jersey
      Rutgers University
    Jan 28, 2022

    End-Stage Kidney Disease, End-Stage Renal Disease Trial in Boston, Minneapolis, New York (Metoprolol Succinate, Carvedilol)

    Not yet recruiting
    • End-Stage Kidney Disease
    • End-Stage Renal Disease
    • Boston, Massachusetts
    • +4 more
    Jun 26, 2023

    Type2 Diabetes Trial in Cairo (Natural Wellness Low-Glu low dose, Natural Wellness Low-Glu high dose, Metformin)

    Completed
    • Type2 Diabetes Mellitus
    • Natural Wellness Low-Glu low dose
    • +2 more
    • Cairo, Nasr City, Egypt
      Natural Welness Egypt
    Apr 27, 2022

    Bone Denisty Change in Children With Beta Thalassemia Major

    Not yet recruiting
    • Evaluate Bone Denisty Changes in Children With Beta Thalassemia Major
    • Dexa scan
    • (no location specified)
    Sep 29, 2023

    Stable Ischemic Heart Disease, Coronary Artery Disease, Beta-blocker Therapy Trial in Edmonton (Medical Assessment, Quality of

    Recruiting
    • Stable Ischemic Heart Disease
    • +2 more
    • Medical Assessment
    • Quality of Life Assessment
    • Edmonton, Alberta, Canada
      University of Alberta Hospital
    Jan 30, 2023

    Pediatric Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations

    Not yet recruiting
    • Congenital Hearing Loss Secondary to Biallelic Mutations in the Otoferlin Gene (OTOF)
    • +2 more
      • (no location specified)
      Aug 25, 2023

      Spleen Stiffness asMeasure to Assess REsponse to ß Blocker

      Not yet recruiting
      • High Risk Esophageal Varices
      • No intervention
      • New Delhi, Delhi, India
        Institute of Liver & Biliary Sciences
      Sep 16, 2023

      Cirrhosis, Liver, Portal Hypertension, Variceal Hemorrhage Trial in London (Carvedilol, Placebo)

      Recruiting
      • Cirrhosis, Liver
      • +3 more
      • London, United Kingdom
        King's College Hospital
      May 23, 2023

      type1diabetes, Type2diabetes, Pre Diabetes Trial in Parma (68Ga-exendin-4, mixed meal test)

      Recruiting
      • type1diabetes
      • +3 more
      • Parma, Pr, Italy
        Azienda Ospedaliero Universitaria di Parma
      Dec 20, 2022

      Diabetes, Type 2, Obesity Trial in Toronto (Time restricted feeding, Standard lifestyle)

      Recruiting
      • Diabetes Mellitus, Type 2
      • Obesity
      • Time restricted feeding
      • Standard lifestyle
      • Toronto, Ontario, Canada
        Leadership Sinai Centre foe Diabetes - Mount Sinai Hospital
      Jan 30, 2023

      Pompe Disease, Glycogen Storage Disease Type II (GSD II) Trial in Worldwide (alglucosidase alfa)

      Completed
      Has Results
      • Pompe Disease
      • Glycogen Storage Disease Type II (GSD II)
      • alglucosidase alfa
      • Valhalla, New York
      • +11 more
      Mar 15, 2022

      Pancreatic Ductal Adenocarcinoma, Gastroesophageal Adenocarcinoma, Glioblastoma Multiforme Trial (68Ga-FF58, 177Lu-FF58)

      Not yet recruiting
      • Pancreatic Ductal Adenocarcinoma
      • +2 more
      • (no location specified)
      Jul 28, 2023

      Type 1 Diabetes Trial in Nijmegen (68Ga-NODAGA-Exendin-4)

      Recruiting
      • Type 1 Diabetes
      • Nijmegen, Gelderland, Netherlands
        Radboud University Medical Center
      Nov 17, 2022

      Aortic Valve Stenosis Trial (Beta blocker)

      Not yet recruiting
      • Aortic Valve Stenosis
      • Beta blocker
      • (no location specified)
      Feb 14, 2023

      Thalassemia, Beta Trial in Karachi (Hydroxyurea and Thalidomide)

      Completed
      • Thalassemia, Beta
      • Hydroxyurea and Thalidomide
      • Karachi, Sindh, Pakistan
        Children's Hospital Karachi
      Nov 23, 2023

      Fabry Disease Trial in Seoul (Fabagal® (Agalsidase beta), Active comparator (Agalsidase beta))

      Recruiting
      • Fabry Disease
      • Fabagal® (Agalsidase beta)
      • Active comparator (Agalsidase beta)
      • Seoul, Songpa-gu, Korea, Republic of
        Seoul Asan Center
      Oct 10, 2023